key: cord-0892221-er4wzsn1
authors: Anuszkiewicz, Karolina; Stogowski, Piotr; Zawadzka, Marta; Waszak, Przemysław; Sokolewicz, Ewa; Dułak, Natalia; Dzwilewski, Kamil; Jażdżewska, Karolina; Karbowiak, Kamila; Karlińska, Daria; Marczak, Anna; Niebrzydowska, Anna; Niebrzydowski, Bartosz; Pasierbska, Ewa; Sadowska, Agnieszka; Szczęsna, Małgorzata; Stanisław Szczęsny, Piotr; Szerszenowicz, Anna; Sztramski, Kamil; Radziwon, Jakub; Tkaczuk, Magdalena; Ziołkowska, Kinga; Mazurkiewicz-Bełdzińska, Maria
title: COVID-19 pandemic influence on epilepsy course in pediatric patients
date: 2022-01-24
journal: Epilepsy Behav
DOI: 10.1016/j.yebeh.2022.108581
sha: 8d75e094849d2bf19f968d3aa4d5170cb3316503
doc_id: 892221
cord_uid: er4wzsn1

INTRODUCTION: In 2020 Coronavirus Disease 2019 (COVID-19) was declared as a global pandemic. Self-reported stress, anxiety, and insomnia, which are believed to be common triggers for epilepsy, are more likely to occur. We aimed to establish the influence of COVID-19 pandemic itself so as changes in the daily life routine related to pandemic on epilepsy course in pediatric patients. The unique form of clinical care which is telemedicine was also taken into consideration. We wanted to evaluate patients' satisfaction with telemedicine and if changing stationary visits into telemedicine influenced epilepsy course in our patients. METHODS: Patients, who attended developmental neurology outpatient clinic in the period March-December 2020 were collected. As patients were minors, legal guardians were asked to fill out the questionnaire. Patients were divided according to the outcome into three groups: those with a worsened, stable or improved course of epilepsy during the pandemic. Appropriate statistical tests for two-group and multi-group comparisons have been implemented. Post-hoc p values were also calculated. RESULTS: 402 questionnaires were collected. Most of the patients had a stable course of epilepsy during the pandemic; in 13% of participants an improvement has been observed, worsening of the disease was seen in 16% of patients. Age, sex, type of epilepsy, number of seizure incidents before pandemic, and duration of the disease had no statistically significant connection with changes in the course of the disease. Behavioral changes and altered sleep patterns were found to be more common in the worsened group. 58% of patients were satisfied with telemedicine. Poorer satisfaction was connected with less frequent visits, cancellation of scheduled appointments, and lack of help in case of need of emergency situation. CONCLUSION: Epilepsy course in pediatric patients seems to be stable during COVID-19 pandemic. Sleep disturbances and changes in a child's behavior may be related to increase in seizures frequency. Telemedicine is effective tool for supervising children with epilepsy. Patients should be informed about possible ways of getting help in urgent cases.

On March 11th, 2020 the World Health Organization declared the outbreak of Coronavirus 2019 (COVID-19) as a global pandemic. Implications that followed this declaration were devastating to economic, social, and health factors. The consequences of the novel coronavirus on physical as well as mental health are currently a major concern [1] . Social distancing was implemented as the main viral transmission prevention technique, leading to loneliness which in turn may further result in depression, anxiety, and chronic stress [2, 3] . To avoid direct contact with patients, for their safety and the safety of healthcare providers, clinical care had to be partially shifted towards telemedicine [4] . Epilepsy is a chronic disease and requires frequent follow-up consultations to provide adequate patients care [5] . Prior studies suggest that COVID-19 may cause worsening of preexisting neurological disorders, some authors reported an increased number of seizures during the pandemic and describe de novo seizures in COVID-19 patients [6] [7] [8] . Although no clear connection between COVID- 19 and epilepsy has been established yet, it is essential to evaluate the effects of the pandemic on common diseases. The pandemic caused an increased occurrence of anxiety, depression, insomnia, and, not surprisingly, changes in sleep pattern and an increase in self-reported stress, which are believed to be common triggers for epilepsy [3, 9, 10] . In our study, we aimed to establish the influence of COVID-19 pandemic itself so as changes in the daily life routine related to pandemic on epilepsy course in pediatric patients. We wanted to evaluate seizure frequency before the pandemic outbreak and during the pandemic and find reasons for possible changes in epilepsy course. The unique form of clinical care which is telemedicine was also taken into consideration as it was significantly different from the standard medical care provided in pediatric patients affected by epilepsy. We wanted to evaluate patients' satisfaction with telemedicine and if changing stationary visits into telemedicine influenced epilepsy course in our patients.

The study was designed as a cross-sectional study. Medical records of patients with an established diagnosis G.40 in International Classification of the Disease (ICD) or diagnosis "epilepsy" according to International League Against Epilepsy (ILAE) definition [11] , who attended the developmental neurology outpatient clinic in the period between March 2020 and December 2020 were collected. The study was conducted in January 2021, by this time period given above corresponded with the time of the pandemic in Poland. The exclusion criteria were: unconfirmed diagnosis of epilepsy and diagnosis made in 2020, as in those patients, the comparison of epilepsy course before and after the pandemic outbreak was impossible. Patients with only one provoked episode of seizure in the past attributed to transient states like fever, hemorrhage, infection were also excluded. Informed consent from the bioethical commission was obtained. Questionnaires were collected using the telephone by one of the research team members. As patients were minors, legal guardians were asked to answer the questions. The consent for participating in the survey was obtained from each participant. The language of the questionnaire was polish. For publication purpose, the questionnaire and answers were translated into English by a university employee, specialized in medical English. All answers were collected anonymously. The study design is presented in Diagram 1.

The questionnaire was designed by a developmental neurologist and neuropsychologist (MZ and MMB), experienced in epilepsy healthcare. It consisted of four sections: demographic data, epilepsy course and treatment, medical care during the pandemic, and additional information. The questionnaire is presented in the appendices.

Control of epilepsy was assessed in 2019 and 2020 separately considering the frequency of seizure episodes per month. A separate question was asked about the change in the course of epilepsy during the pandemic. If the answer "no change" was marked, the patient in question was placed in the group "Stable". Answering "yes" in the questionnaire resulted in an additional question: "What change was observed?". The following answer possibilities were given: 1. more frequent occurrence of seizures, 2. less frequent occurrence of seizures, 3. more severe or longer epilepsy episodes, 4. less severe or shorter epilepsy episodes, 5.

occurrence of a new type of seizures. Participants, who responded 1., 3., or 5. were placed in a group consisting of patients with a "worsened course of epilepsy", persons, who responded 2. or 4. were placed in the group which experienced an "improved course of epilepsy ".

Raw data were collected in Excel spreadsheets (Microsoft, USA). Statistical analysis was performed using the STATISTICA 10.0 software (StatSoft Inc., USA). All of the quantitative variables were tested using the Kolmogorov-Smirnov test, for meeting the criteria of a normal distribution (Gaussian distribution). Depending on whether the variable met the normality condition, appropriate statistical tests were applied at further stages. Continuous data were presented as median and quartiles if they did not meet the conditions of the normal distribution. For comparisons between two groups the parametric T-test or nonparametric Mann-Whitney U Test, were used. For the comparison of multiple groups, the Analysis of variance ANOVA test (for variables of parametric distribution) or Kruskal-Wallis test (variables of non-parametric distribution) were used. For comparing qualitative survey data the Pearson's chi-square test (with appropriate Yates' Correction for small observed frequencies) was used. In next step, the post-hoc Chi-square analysis was performed, based on adjusted residuals of each variable. [12] The Bonferroni correction was also implemented, as this adjustment is commonly used to protect from Type I error in multiple comparisons. The level of statistical significance in calculations was set at the p<0,05 or correspondingly lower, if determined by the Bonferroni correction.

We identified 622 patients in total. Fifty-two patients were excluded due to one of the exclusion criteria. Seventy-eight guardians refused to take part in the survey, fifty-four did not answer the telephone (three contact attempts were made), fourteen did not finish the questionnaire and in twenty-two cases the contact number in the medical records turned out to be incorrect. Eventually, 402 questionnaires were collected with a response rate of 70,53%.

All demographic data are detailed in Table 1 .

Characteristic of each group is presented in Table 2 .

Participants were divided into three groups, based on the course of their disease during the COVID-19 pandemic: Improved, Stable (unchanged epilepsy course) and Worsened.

Two hundred eighty-four patients (70.6%) were in the "Stable" group, Changes in the epilepsy course were found in one hundred eighteen patients (29.4%).

Sixty-six (16.4%) patients experienced worsening of the course of epilepsy ("Worsened"). When asked to define the change: 25 declared more frequent occurrence of seizures, 10 more severe or longer seizures, 10 patients had new type of seizures and 21 claimed to have more than one mentioned above. Patients were asked about the month, in which poorer control appeared. The most frequently named month was November 2020 (21.52%), although no statistically significant correlation was found. In this group of children seizure frequency in 2019 compared to 2020 varies, as in 2020 patients had statistically more seizure compared to the year before. This significant spread was especially evident in the subgroups experiencing more than 20 seizures and not experiencing any seizures.

Fifty-two patients (12.9%) were assigned to the "Improved" group. When asked to define the change: 30 declared less frequent occurrence of seizures, 5 less severe or shorter seizures and 17 claimed to have both. In this group of children seizure frequency in 2019 compared to 2020 varies, as in 2020 patients had statistically fewer seizure compared to the year before.

All factors associated with epilepsy course are presented in Table 3 .

In the Improved group 76.9% of the patients (40/52) attended school/kindergarten, in the group Stable -90.1% (256/284) and in the group Worsened 86.4% (57/66). School problems during the pandemic such as worse school grades or lack of concentration were noticed in 31.5% of patients, no significant differences were found between groups.

Changes in a child's behavior during pandemic were seen by 33.3% of parents. The most common problems were irritability (78.4%), avoiding contact with the household members (19.4%), fear of leaving the house (18.7%), presence of somatic problems such as headaches (17.2%). Statically significant differences were noted between groups as children in the group "Improved" did not experience changes in behavior as often as other groups. Statically significant differences were noted between groups as children in the group "Improved" did not experience changes in behavior as often as other groups.

41.7% of patients suffered from any kind of infection during the COVID-19 pandemic, no differences between the groups were seen. Twenty-nine children suffered from COVID-19 infection, confirmed by polymerase chain reaction test (PCR). Symptoms declared were: fever above 38 degrees of Celsius (10/29), taste and olfactory disturbances (7/29), headaches Three of those children had fever above 38 degrees of Celsius, one had only taste and olfactory disturbances.

Telemedicine appointments were conducted in all three groups. "Improved" group declared those appointments were as effective as standard medical appointments more often than other groups, although no statistically significance was achieved (p=0.07). Changes in medical appointments frequency during pandemic were more often declared in the "Worsened" group (p=0.001).

Eighty-one of participants claimed difficulty with drugs supplies during the pandemic; 95.1% of them reported no drug availability in drug stores, the other 4.9% had a problem with reaching pharmacy because of quarantine.

Three hundred forty-one (84.8%) patients had at least one telemedicine appointment.

There was no statistically significant change in frequency of seizure episodes between 2019 and 2020 in those patients; 199 of them (58.4%) stated online visits were as efficient as the standard medical appointments. In 82.9% of cases in this group consultations were performed as often as before the pandemic; 142 of the patients (41.6%) found telemedicine less satisfactory and in this group in 62.0% of cases the visits took place as often as before the pandemic. A statistically significant correlation between satisfaction with telemedicine and frequency of appointments was found (p=0.0001). In 13.48% of unsatisfied patients neurologists canceled a scheduled appointment, compared to 4.52% of patients in the satisfied group (p=0.003). About one-quarter of patients in each group required urgent hospitalization or consultation in addition to the scheduled appointments, almost all patients (97.83%) from the satisfied group managed to get help, while 32.50% of patients from the unsatisfied group no medical support was provided (p=0.001). There was no correlation between patient's satisfaction and distance to the clinic.

Further information about the groups is presented in Table 4 .

The study investigated the effect of the COVID-19 pandemic on epilepsy course in pediatric patients and, according to our knowledge, is the first study, which correlates changes in epilepsy course during COVID-19 with changes in daily routine and in epilepsy healthcare in pediatric population. In most of our patients, the disease had a stable course. If the course has changed, worsening (16.4%) was observed slightly more commonly than improvement (12.9%). Groups did not differ in the median age of children, epilepsy type, or duration of the disease. Furthermore, seizure frequency before pandemic was also similar in each group. A few studies investigated the impact of the COVID-19 pandemic on epilepsy course in adults.

Worsening was observed in 17-25% of the adult population [13] [14] [15] . It correlated with more stress and anxiety in those patients. COVID-19 pandemic has an undeniable influence on the mental health of the patients. More than half of adults experiencing epilepsy declared an increase in stress level during the pandemic [10] . Adults expressed their fear of losing a job, financial problems, hospitalization, or concern of loved ones [14] . However, we need to remember that patients in our study had a median age of 11 years old. The concerns mentioned above are usually irrelevant for the children. Our results are compatible with Trivisano et al. study, as they resulted seizure frequency during COVID-19 was unchanged 66.5% of pediatric population, increased in 13.3% and decreased in 20.3% of children [16] .

The situation of global lockdown with closed schools, online classes, and online exams could provide a less stressful environment for children. Studies suggest that the well-being of young children (age group 6-10 years old) did not change during the time of the pandemic. In addition, almost half of the parents claimed improvement of their parent-child relationship during lockdown [17] ; furthermore, most of the caregivers do not report that pandemic had a negative influence on the mental health of their children [18] .

In our survey, subjects, who declare worsening in seizure control were more likely to have sleep disturbances and new changes in the child's behavior like irritability. Most commonly mentioned problems were: troubles falling asleep, waking at night, and disturbances of the circadian rhythm. Undeniably, a lack of daily routine could influence those aspects. It may reflect in hyperactivity and, in consequence, irritability, anger, or avoiding contact with household members [17] . Some children can be more susceptible to changes in daily routine, which can affect their disease. Moreover, children are susceptible to emotions present at home. Even if the global healthcare crisis did not influence them directly, it might have had an impact on their parents. An increase in parental stress could directly interfere with the life quality of adolescents [19] . For this reason, doctors should evaluate stress level in young patients and also their caregivers, asking questions about sleep, activities, and mood.

Some patients and their families might require psychological support. General advice about sleep, a healthy lifestyle, and maintaining physical activity should be given [20] . Future studies should investigate stress levels not only in children but also in their household members.

Almost 13% of patients had improvement in the course of their disease. No differences comparing this group to the rest of the patients were found. Epilepsy has a natural tendency to a sinusoidal course, consisting of remissions and exacerbations. According to Sander et al.

about 70-80% of patients will go into long-term remission, usually within the first 5 years [21] .

The question remains -is it attributable to the COVID-19 pandemic or just a natural course of epilepsy? Follow-up of those patients could be useful for answering whether the improvement was temporary or not and if the frequency of seizures returns to baseline after the pandemic.

Infections can be a potential trigger of seizures in children, especially combined with fever [22] . In our study, 29 patients were diagnosed with COVID-19. Four parents declared worsening of the course of epilepsy related to COVID-19 infection. Three of those children suffered from high fever, which can be an independent seizure trigger, despite SARS-CoV-2 virus infection. The relation between COVID-19 and epilepsy is not clear [23] . The disease itself causes a systematic inflammatory reaction presenting with a high fever and symptoms from the respiratory tract. The influence of the SARS-CoV-2 virus on the brain and a potential mechanism of epilepsy is still controversial. In literature case reports and case series of patients with new-onset seizures (focal or general) in the course of COVID-19 infection are reported [7] . The potential mechanism involves the entry of pro-inflammatory cytokines into the nervous system, an increase of glutamate and aspartate, and a reduction of gammaaminobutyric acid (GABA) levels [24] . All of these can provoke more seizures in patients affected by epilepsy. More data should be collected to establish an undeniable connection.

The great concern of this report is access to healthcare providers and drug supplies during the pandemic. Proper anti-epileptic therapy is crucial for a seizure-free course of epilepsy. In the consensus published in Neurology in May 2020 stockpiling of medication is discouraged [20] . However, 20% of responders had problems with drug availability during the pandemic, due to lack of medications in pharmacies and being on quarantine. Considering those situations, it may be useful for patients to have supplies of appropriate medications for upcoming weeks. Taking medication regularly is crucial. Every pause could be catastrophic for seizure control.

Telemedicine has a great potential for increasing the availability of patient care.

Current communication tools provide access to healthcare regardless of the distance from the hospital and patient's mobility. One of its major limitations is the reduced ability to perform a physical examination; however, in epilepsy treatment, especially in follow-up management physical examination is rarely necessary [9, 25] . Prior studies of adult subjects showed that telephone consultations were effective and efficient in providing remote epilepsy care [13, 20] . Moreover, telemedicine has the potential of addressing limited resources and improving access to people with epilepsy across the globe [26, 27] . In our study, 58% of subjects consider the effectiveness of epilepsy treatment via telephone consultation as qualitatively equal to a stationary visit in the outpatient clinic. No significant changes in the epilepsy control were noted in both, satisfied and dissatisfied patients. Teleconsultation did not influence epilepsy control, comparing the frequency of seizure episodes in 2019 and 2020.

We assumed that patients living at a great distance from the clinic would be more satisfied with telemedicine, but no correlation was found. Mentioned results suggest that telemedicine is a good, sufficient tool, especially from the medical point of view. For a doctor, the major point in epilepsy management is a stabile seizures frequency, which, according to our results, may be achieved by telemedicine. Long-term epilepsy management is mainly based on a detailed interview with the patient or patient's caregivers, which can be potentially accomplished by a phone call. Previous studies support those statements as telemedicine consultations were successfully utilized as an important tool for epilepsy management regardless of epilepsy type, etiology, seizure frequency, comorbidities, and patients' residential areas [28] . It was also used with a success in diagnosis and managing childhood absence epilepsy [29] . Telemedicine may also provide high satisfaction and economic benefits in the future, after the pandemic [30] . However, Kubota et al. described a connection between telemedicine appointments and a higher incidence of status epilepticus [31] . Results of van Wrede et al. pointed more potential disadvantages such as lack of personal contact and diagnostics (electroencephalogram [EEG] recordings, blood analysis) and, eventually, about three-fourth of the participants wished to have further appointments face-to-face [32] .

Telemedicine has great potential, but it may not be enough if it is the only tool for supervising the patient, which should be considered by the doctors.

Although previous studies reported high satisfaction of the patients with telemedicine, in our study 40% of the patients were not satisfied [33] . One of the major reasons for dissatisfaction might have been the lower frequency of consultations as a group of dissatisfied patients reported less frequent visits than before the pandemic. Canceling teleconsultation by the neurologist was another reason for the poorer satisfaction. Those disadvantages could be easily removed by regularly scheduled visits. Alarming is the fact that one-third of unsatisfied patients did not manage to get help when the need for an urgent consultation appeared. In the era of COVID-19, many emergency departments and hospitals are limited only to COVID-19 positive patients. Patients with chronic diseases should be informed about possible ways to contact doctors beyond scheduled appointments. Doctors should ensure patients, that despite the tough time of the pandemic, their disease is still important and fully cared for.

Our study has its limitations. The study is a cross-sectional study, which cannot determine the causality between the associated factors and is based on the univariate analysis, which cannot consider the confounding factors. The questionnaire has no validation as there is no validated questionnaire on this topic. As the patients were minor, the questionnaires were filled out by their legal guardians, the questions about subjective feelings about stress had to be excluded. The answers were collected by phone call. Although the data were saved anonymously, responders might have felt embarrassed or not comfortable with answering honestly, directly to the employee of the clinic. Nonetheless, neurologists, who directly treat patients did not take part in collecting questionnaires. The seizure frequency was based on caregivers' answers. The questions were asked retrospectively and were related to the period of seven months, so recall bias was unavoidable; however, according to our experience, parents of children with epilepsy are very focused on their child's disease and can easily observe changes in the course of the epilepsy. We advise them to keep "seizure diaries", so in many cases we could evaluate carefully frequency of seizure.

Epilepsy course in pediatric population seems to be stable during COVID-19 pandemic.

Sleep disturbances and changes in a child's behavior may be related to increase in seizures frequency. Problems with pharmacy stores supplies and being on quarantine may cause difficulty with the availability of medications. Teleconsultations seem to be an efficient tool for providing healthcare to children with epilepsy. Regularity of consultations should be kept, and another date should be set in case of cancellation. Patients should be informed about possible ways of getting help in case of urgent medical needs.

None. 1. An increased frequency of epilepsy episodes? 2. A decreased frequency of epilepsy episodes?

3. An increased intensity of epilepsy episodes? 4. A decreased intensity of epilepsy episodes?

5. An occurrence of new type of epilepsy episodes/new set of symptoms?

Highlights:

-The majority of the patients had a stable course of the disease during the pandemic -Pandemic had an influence on children behavior and sleep patterns -Telemedicine seems to be an effective tool for supervising children with epilepsy -Patients should be informed about possible options in case of emergency

Epidemiology of mental health problems in COVID-19: A review

Does COVID-19 Spread Through Droplets Alone?

Social isolation in Covid-19 : The impact of loneliness 2020

Using Telemedicine During the COVID-19 Pandemic

Approach to the patient with epilepsy in the outpatient department

Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19 : A systematic review

COVID-19, de novo seizures, and epilepsy: a systematic review

COVID-19 and seizures: Is there a link?

Epilepsy care in the COVID-19 era

The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with

ILAE Official Report: A practical clinical definition of epilepsy

Multiple Regression Approach to Analyzing Contingency Tables: Post Hoc and Planned Comparison Procedures

Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: The patient perspective

Epilepsy during the COVID-19 pandemic lockdown: a US population survey

Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening

Impact of COVID-19 pandemic on pediatric patients with epilepsy -The caregiver perspective

Stress, resilience, and well-being in Italian children and their parents during the COVID-19 pandemic

The impact of covid-19 on health behavior, stress, financial and food security among middle to high income canadian families with young children

The potential impact of the COVID-19 pandemic on child growth and development: a systematic review

Keeping people with epilepsy safe during the COVID-19 pandemic

The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment

Seizureprecipitating factors in relation to medical recommendations: Especially those limiting physical activity

Status epilepticus and COVID-19: A systematic review

How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms

Telephone review for people with epilepsy

Managing Epilepsy by Telemedicine in Resource-Poor Settings

Telemedicine in epilepsy: How can we improve care, teaching, and awareness?

Diagnosing and managing childhood absence epilepsy by telemedicine

Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic

Association between telemedicine and incidence of status epilepticus during the COVID-19 pandemic

Counseling of people with epilepsy via telemedicine: Experiences at a German tertiary epilepsy center during the COVID-19 pandemic

Telemedicine and epilepsy: A patient satisfaction survey of a pediatric remote care program